NEW YORK, Dec. 31, 2024 /PRNewswire/ — AnaChart, a New York based Fintech company, has identified the top stock research analyst performances which rose to the occasion with their insightful predictions and consistent delivery in the year of 2024. Analysis was conducted using an algorithm which measures each analyst’s forecasts over the year across all the stocks that they cover. In 2024, the majority in the list are represented by experts within the industrials and technology sectors. Recognition is attributed per individual stock forecasting instead of overall performance due the variances between individual securities success.
From the words of AnaChart CEO Joseph Kalish “S&P 500 had over 36% return in 2024 with the hi-tech sector leading the way, still, going on limb and providing price targets that materialize in a timely manner with substantial potential upside and doing so consistently and outperforming the market is something that might be considered impossible by some members of the finance community yet here we are”
The winners for 2024 are:
Honorable mentions for analysts that had repeated double digit returns with their price targets
About AnaChart: revolutionizing the fintech industry as an equity research support platform. Founded in 2020, it uses “radical transparency”[1] to provide up-to-date price targets and ratings from top stock analysts for each company. From past performance history to current projections, AnaChart offers an unprecedented view into analyst insights that can vastly improve investment decision making process.
[1] Radical Transparency is a term coined by Ray Dalio of Bridgewater to encourage an open and honest dialogue, allowing the best thinking to prevail.
Contact:
Mark Hake
+12018295266
388178@email4pr.com
SOURCE AnaChart
PROVIDENCE, R.I., March 31, 2025 /PRNewswire/ -- The Rhode Island Life Science Hub and Brown…
COLOGNE, Germany and SEOUL, South Korea, March 31, 2025 /PRNewswire/ -- Medit, a global leader…
HONG KONG, March 31, 2025 /PRNewswire/ -- Guo Guangchang, Chairman of Fosun International Limited (HKEX:…
GE HealthCare has completed its acquisition of Sumitomo Chemical’s 50% stake in Nihon Medi-Physics (NMP),…
SHANGHAI, March 30, 2025 /PRNewswire/ -- As the clear aligner business enters the second quarter of 2025,…
Preliminary data from Cohort 4 of the ENSURE study supports a novel enrichment strategy to…